2023
DOI: 10.1016/j.vetmic.2023.109678
|View full text |Cite
|
Sign up to set email alerts
|

Recombinant porcine Interferon-α and Interleukin-2 fusion protein (rPoIFNα+IL-2) shows potent anti-pseudorabies virus activity in vitro and in vivo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

2
1

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 33 publications
0
2
0
Order By: Relevance
“…Previous studies have shown that an H7N9 subunit vaccine designed using a combination of highly immunogenic epitopes and linkers could result in a strong immune response ( Hasan et al, 2019 ). Meanwhile, our study results suggested that a recombinant porcine IFN-α and IL-2 fusion protein ( rPoIFNα+IL-2 ) has both the antiviral effect of IFNα and the pro-proliferation effect of IL-2 ( Zhao et al, 2023 ). These results suggest that multiple epitopes or structural domains expressed in tandem play coordinating roles.…”
Section: Discussionmentioning
confidence: 87%
See 1 more Smart Citation
“…Previous studies have shown that an H7N9 subunit vaccine designed using a combination of highly immunogenic epitopes and linkers could result in a strong immune response ( Hasan et al, 2019 ). Meanwhile, our study results suggested that a recombinant porcine IFN-α and IL-2 fusion protein ( rPoIFNα+IL-2 ) has both the antiviral effect of IFNα and the pro-proliferation effect of IL-2 ( Zhao et al, 2023 ). These results suggest that multiple epitopes or structural domains expressed in tandem play coordinating roles.…”
Section: Discussionmentioning
confidence: 87%
“…Subsequently, pCold-Fiber1/2-knob and pCold-Fiber2 were transferred into Escherichia coli BL21 separately for expression of 2 fusion recombinant proteins as previously described ( He et al, 2018 ). The protein was purified using Ni-agarose resin (Kangwei, Beijing, China) as previously described ( Zhao et al, 2023 ). The subunit vaccines were prepared by emulsifying recombinant proteins with Freund's complete adjuvant at a volume ratio 1:1 which the protein content was calculated as 100 μg/mL.…”
Section: Methodsmentioning
confidence: 99%